Clinical Trials
161 trialsOxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
ARFIM
Institut Bergonié
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Roswell Park Cancer Institute
TAP
Trinity Health Michigan
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
University of California, San Francisco
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
PeLear CCC
University of North Carolina, Chapel Hill
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Study of Colorectal Cancer Screening Options
Kaiser Permanente
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
City of Hope Medical Center
Evaluating Online Messages About Colon Cancer Screening
University of Utah
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
New Mexico Cancer Research Alliance
EXACT
Pennington Biomedical Research Center
Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal Surgery
Trinity Health Michigan
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
NuCana plc
COCHISE
Institut Bergonié
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
Academic and Community Cancer Research United
Glucagon Use in Colonoscopies
University of California, San Francisco
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
UNC Lineberger Comprehensive Cancer Center
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Academic and Community Cancer Research United
Neoadjuvant Therapy for Locally Advanced Colon Cancer
Zhejiang University
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab
TheraOp
Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis
Weill Medical College of Cornell University
Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
Adjuvant Aspirin Treatment for Colon Cancer Patients
Swiss Cancer Institute
The United States Healthy Living Study
University of Florida
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
NRG Oncology
Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon Cancer
Jilin University
A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care
University of Florida
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
NuCana plc
Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps
Washington University School of Medicine
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Ohio State University Comprehensive Cancer Center
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction
Karaganda Medical University
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Case Comprehensive Cancer Center
M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability
M.D. Anderson Cancer Center
Association of Anemia With Hospital Costs in Elective Colorectal Surgery
Ottawa Hospital Research Institute
Prehab
Medical College of Wisconsin
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mailed FIT Outreach 2022
Abramson Cancer Center at Penn Medicine
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Columbia University
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
Ohio State University Comprehensive Cancer Center
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Augusta University
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
Academic and Community Cancer Research United
Effectiveness and Implementation of mPATH-CRC
Wake Forest University Health Sciences
Ipilimumab and Local Radiation for Selected Solid Tumors
Stanford University